Felicia Vonella | Director of IR |
Ron Cohen | President and CEO |
David Lawrence | Chief, Business Operations and Principal Accounting Officer |
Michael Yee | Jefferies & Company |
Phil Nadeau | Cowen and Company |
Charles Duncan | Piper Jaffray |
Laura Chico | Raymond James |
Jay Olson | Oppenheimer |
Welcome to the Acorda Therapeutics' Fourth Quarter 2017 Updates. At this time, all participants are in a listen-only mode. There will be a question-and-answer-session to follow. Please be advised that this call being taped at the company's request. I will now introduce your host for today's call, Felicia Vonella, Executive Director of Investor Relations at Acorda.